Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

Abstract Background Chronic obstructive pulmonary disease (COPD) is a chronic progressive inflammatory disease of the airways, associated with frailty, disability, co-morbidity, and mortality. Individuals with COPD experience increased risk and rates of acute exacerbation as their lung disease worse...

Full description

Bibliographic Details
Main Authors: Juthaporn Cowan, Sunita Mulpuru, Shawn Aaron, Gonzalo Alvarez, Antonio Giulivi, Vicente Corrales-Medina, Venkatesh Thiruganasambandamoorthy, Kednapa Thavorn, Ranjeeta Mallick, D. William Cameron
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Pilot and Feasibility Studies
Subjects:
Immunoglobulin
COPD
COPD exacerbation
Pilot study
Randomized clinical trial
Feasibility and safety
Online Access:http://link.springer.com/article/10.1186/s40814-018-0327-z

Internet

http://link.springer.com/article/10.1186/s40814-018-0327-z

Similar Items